A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was 'Should patients undergoing cardiac surgery with atrial fibrillation (AF) have left atrial appendage (LAA) exclusion?' Altogether 310 papers were found using the reported search, of which 12 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. We conclude that despite finding five clinical trials including one randomised controlled trial, that studied around 1400 patients who underwent LAA occlusion, the results of these studies do not clearly show a benefit for appendage occlusion. Indeed of the five studies, only one showed a statistical benefit for LAA occlusion, with three giving neutral results and in fact one demonstrating a significantly increased risk. One reason for this may be the inability to achieve acceptably high rates of successful occlusion on echocardiography when attempting to perform this procedure. The highest success rate was only 93% but most studies reported only a 55-66% successful occlusion rate when attempting closure in a variety of methods including stapling, ligation and amputation. Currently, the evidence is insufficient to support LAA occlusion and may indeed cause harm especially if incomplete exclusion occurs.
Introduction
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS w1x.
Clinical scenario
You are performing a left atrial radiofrequency MAZE procedure on a patient who is also undergoing bypass grafting. It is your practice to also oversew the left atrial appendage (LAA) after this. While doing this, however, the thin left atrium tears and you spend the next 20 min repairing this tear with pledgets. As you comment to the anaesthetist that you wish that you had never tried to oversew the appendage, he also comments that on transoesophageal echocardiography (TOE) he often still sees quite a long residual stalk anyway and you both wonder if there really is an advantage to LAA removal.
Three-part question
In wpatients undergoing cardiac surgery with atrial fibrillationx does wexclusion of the left atrial appendagex protect from wthromboembolic complicationsx. *Corresponding author. Tel.: q44 (0) 7763376000. E-mail address: alan.g.dawson.04@aberdeen.ac.uk (A.G. Dawson).
Search strategy
Medline 1950 to May 2009 using OVID interface wexp Atrial Appendageyor left atrial appendage.mp OR (appendage.mp AND atr$.mp)x AND wexcision.mp OR exclusion.mp OR ligation.mp OR occlusion.mp OR closure.mp OR obliteration.mpx
Search outcome
Three hundred and ten papers were found using the reported search from which 12 papers were identified that provided the best evidence to answer the question. These are presented in Table 1 .
Results
There are two issues to address in this topic: is the LAA an important source of emboli in patients with AF and whether exclusion of the LAA reduces the incidence of thromboembolic events.
Left atrial appendage and source of emboli
Studies have concluded that approximately 90% of left atrial thrombi are located in the LAA w14, 15x. It follows that successful closure of the LAA should aid in reducing Downloaded from https://academic.oup.com/icvts/article-abstract/10/2/306/645610 by guest on 27 February 2019 the risk of thromboembolic events in patients with AF w16x. Indeed, recurrent and persistent AF in patients who remain symptomatic with heart rate control and where antiarrhythmic medication is not tolerated or no longer effective, then LAA ablation should be considered w17x. occlusion. Successful LAA occlusion was identified in only 66% of their study population, although this rate improved with experience.
Exclusion of the LAA and thromboembolic events
Perioperative thromboembolic events were recorded for two patients; one an intraoperative ischaemic stroke and the other a transient ischaemic attack (TIA). No thromboembolic events were recorded during follow-up. Surveys were sent to all eligible patients for the study, but who chose not to participate and it showed that 12% selfreported a thromboembolic event (12 strokes and 13 TIAs).
During a 12-month period, Schneider et al. w3x examined six patients who received LAA closure at the time of mitral andyor aortic valve surgery. Postoperative TOE demonstrated successful closure in one patient. One patient experienced a stroke four weeks postoperatively despite a high level of anticoagulation.
Bando et al. w4x examined 812 patients following mitral surgery of whom 55% had their LAA ligated. Seventy-two patients experienced a late stroke. Of the 72 patients, 65% had the LAA ligated.
In 2008, Kanderian et al. w5x examined 137 patients who underwent LAA closure. They demonstrated that only 55% of their patients had successful closure of the LAA. They reported that 52 patients had excision of the LAA (41 by scissors and 11 by a stapling device) and 85 received exclusion of the appendage of which 73 were by suture and 12 by stapler excision. It was found that successful occlusion occurred more often with excision of the LAA (73%) relative to suture and stapler exclusion (23% and 0%, respectively). Six of 55 patients with successful closure experienced a stroke or TIA compared with 12 of 82 patients who had unsuccessful LAA closure, which was not significant.
García-Fernández et al. w6x examined 205 patients undergoing mitral valve surgery of which 58 patients received LAA ligation. Successful ligation was present in 89.7%. Twenty-seven patients, two of whom had their LAA ligated, experienced thromboembolic complications; 19 patients had an ischaemic stroke, five patients had a peripheral arterial embolism, and three patients experienced a TIA. Consequently, it was found that the occurrence of systemic emboli was more frequent among patients without relative to patients who had received LAA ligation. Moreover, this study demonstrated that the absence of ligation of the LAA was an independent predictor of the occurrence of an embolic event following mitral valve surgery with an odds ratio of 6.7. If the absence of effective ligation is incorporated into the model, the odds ratio increased to 11.9.
Orszulak et al. w7x examined 285 patients undergoing mitral valve replacement (MVR). Ninety-two patients received operative ligation of the LAA. This study found an increased rate of late stroke in patients who had the LAA ligated.
In 2000, Johnson et al. w8x studied 437 patients who received exclusion of the LAA during open heart surgery. Perioperative cerebrovascular accidents (CVAs) occurred in 21 patients despite no patients being identified by TOE to have intra-atrial clots. Seven patients developed a CVA postoperatively, four of whom were in AF, but no atrial clots were demonstrated on TOE. Katz et al. w9x analysed 50 patients undergoing LAA ligation during MVR surgery. Incomplete ligation was detected in 36% of patients. Four patients with an incompletely ligated LAA had thromboembolic phenomena (one stroke; one TIA and two mesenteric emboli).
Almahameed et al. w10x studied 136 patients who underwent LAA ligation at the time of mitral valve surgery. Fourteen (12.3%) patients experienced thromboembolic events. They found a significantly increased rate of stroke in patients with LAA occlusion.
Fumoto et al. w11x studied 14 mongrel dogs implanted with the third-generation atrial exclusion device in their LAA. The right atrial appendage was stapled with commercial apparatus for comparison. LAA exclusion was complete and achieved without haemodynamic instability, and coronary angiography revealed that the left circumflex artery was patent in all cases.
Sick et al. w12x reported their experience with the WATCH-MAN LAA occlusion device. The device was implanted into 75 patients, of whom 66 had successful implantation (88%).
Complete closure of the LAA was observed in 93%. Three patients experienced device failure, two of which were embolisations and one was a delivery system failure due to a fractured wire. Kamohara et al. w13x analysed ten mongrel dogs with the second generation atrial exclusion device implanted at the base of the LAA. This was performed without complication in all dogs.
Clinical bottom line
Despite finding five clinical trials including one randomised controlled trial that studied around 1400 patients who underwent LAA occlusion, the results of these studies do not clearly show a benefit for appendage occlusion. Indeed of the five studies, only one showed a statistical benefit for LAA occlusion, with three giving neutral results and in fact one demonstrating a significantly increased risk. One reason for this may be the inability to achieve acceptably high rates of successful occlusion on TOE when attempting to perform this procedure. The highest success rate was only 93% but most studies reported only a 55-66% successful occlusion rate when attempting closure in a variety of methods including stapling, ligation and amputation. Currently, the evidence is insufficient to support LAA occlusion and may indeed cause harm especially if incomplete exclusion occurs. Currently procedures for atrial fibrillation (AF) surgery with radiofrequency (RF) ablation are focused principally on the left atrium (LA), but there is no consensus about LA appendage management. Dawson et al. w1x found that there is no convincing evidence to generalize the LA appendage exclusion since stroke or similar events seem to be similar whether the LA appendage is excluded or not.
This has been the eternal dilemma in the course of intraoperative RF ablation for AF. When I began to work in the field of AF and mitral valve surgery, I found that when the LA is excised and divided in order to reach a LA reduction, a circumferential band of LA tissue is obtained, with the LA appendage included w2x. In other words, this technique constitutes a method to eliminate the AF and, at the same time, to remove the LA appendage. In the first phase of this technique, 13% of the patients remained in AF, but no stroke or similar events were observed w3x. Nevertheless, the evolution of this technique towards pulmonary veins isolation as the fundamental aspect in AF surgery w4x puts again in evidence the old problem: what to do with the LA appendage while performing intraoperative RF ablation?
My personal opinion is that the only method that offers maximal security to exclude the LA appendage is the cut-and-sew on its base. This technique can be from inner or outer of the LA. The risk of bleeding may be present because the LA wall at this point tends to be very thin. On the other hand, we must consider that the majority of the patients treated by this means are under oral anticoagulant therapy due to implanted prostheses or recurrent AF. So, keeping in mind the above-mentioned as regards to stroke and anticoagulation, LA appendage exclusion must be reserved for such cases considered as giant LA with a diameter by echocardiography )8 cm w4x.
